Tyler Williamson

Dr. Tyler Williamson

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Clinical and Translational Radiation Oncology
Verified
Journal Article
Open access
SMShalini Moningi
Shalini Moningi
ELEthan Ludmir
Ethan Ludmir
PPPraveen Polamraju
Praveen Polamraju
TWTyler Williamson
Tyler Williamson
MMMarcella M. Melkun
Marcella M. Melkun
EHEmma Brey Holliday
Emma Brey Holliday
Pelvic reirradiation (re-RT) presents challenges due to concerns for late toxicity to tissues-at-risk including pelvic bone marrow (PBM). We routinely utilize a hyperfractionated, accelerated re-RT for recurrent rectal or anal cancer in the setting of prior radiation. We hypothesized that proton beam radiation (PBR) is uniquely suited to limit doses to pelvic non-target tissues better than photon-based approaches. All patients who received hyperfractionated, accelerated PBR re-RT to the pelvis from 2007 to 2017 were identified. Re-RT was delivered twice daily with a 6 h minimum interfraction interval at 1.5 Gray Relative Biological Effectiveness (Gy(RBE)) per fraction to a total dose of 39-45 Gy(RBE). Concurrent chemotherapy was given to all patients. Comparison photon plans were generated for dosimetric analysis. Dosimetric parameters compared using a matched-pair analysis and the Wilcoxon signed-rank test. Survival analysis was performed Kaplan Meier curves. Fifteen patients were identified, with a median prior pelvic RT dose of 50.4 Gy (range 25-80 Gy). Median time between the initial RT and PBRT re-RT was 4.7 years (range 1.0-36.1 years). In comparison to corresponding photon re-RT plans, PBR re-RT plans had lower mean PBM dose, and lower volume of PBM getting 5 Gy, 10 Gy, 20 Gy, and 30 Gy (p < 0.001, p < 0.001, p < 0.001, and p = 0.033, respectively).With median 13.9 months follow-up after PBR re-RT, five patients had developed local recurrences, and four patients had developed distant metastases. One-year overall survival following PBR re-RT was 67.5% and one-year progression free survival was 58.7%. No patients developed acute or late Grade 4 toxicity. PBR re-RT affords improved sparing of PBM compared with photon-based re-RT. Clinically, PBR re-RT is well-tolerated. However, given modest control rates with definitive re-RT without subsequent surgical resection, a multidisciplinary approach should be favored in this setting when feasible.

1 November 2020 in Advances in Radiation Oncology
Verified
Journal Article
Open access
AMAmy C. Moreno
Amy C. Moreno
JGJillian R. Gunther
Jillian R. Gunther
SMSarah Milgrom
Sarah Milgrom
CFC. David Fuller
C. David Fuller
TWTyler Williamson
Tyler Williamson
CPChelsea C. Pinnix
Chelsea C. Pinnix
Intensity modulated radiation therapy delivered with deep-inspiration breath hold (IMRT-BH) provides favorable normal tissue dosimetric profiles when treating patients with mediastinal lymphoma. However, it is unclear if IMRT-BH plans are comparable to free breathing (FB) proton plans. We performed a retrospective, comparative dosimetric study between IMRT-BH and FB passive scatter proton therapy (P-FB) or intensity modulated proton therapy (IMPT-FB). Hypothesizing that BH would provide superior normal tissue sparing when added to proton therapy, we also compared plans to passive scatter BH (P-BH). For 15 patients who received involved-site RT with “butterfly” IMRT-BH, 3 additional proton plans (P-FB, IMPT-FB, P-BH) were optimized to deliver 30.6 Gy/Gy relative biological effectiveness. Dosimetric variables (mean dose, V30, V25, V15, and V5) for organs at risk (OARs) were calculated and compared using nonparametric Wilcoxon signed-rank tests. Of 57 studied OAR parameters, IMRT-BH plans were comparable in 37 (65%) parameters with P-FB plans, 32 (56%) of IMPT-FB parameters, and 30 (53%) of P-BH parameters. Doses to breasts were generally equivalent among plans while esophageal dosing was worse with IMRT-BH. Mean doses and V5 of the total lung and heart were the highest with IMRT-BH; however, IMRT-BH resulted in comparable coronary and superior lung V30 relative to proton plans. The addition of BH with proton therapy resulted in the greatest lung sparing, with mean lung dose reductions of 11% to 38%. The use of BH with IMRT reduces the disparity in OAR doses with equivalence achieved in nearly two-thirds of OAR metrics compared with P-FB and 50% compared with IMPT-BH. Because each modality exhibited unique benefits, personalization of modality selection is recommended. Proton therapy via BH provides additional benefits in heart and lung sparing.

27 March 2025 in Physics in Medicine & Biology
Verified
Journal Article
Open access
IVIvan Vazquez
Ivan Vazquez
DLDanfu Liang
Danfu Liang
RSRamon M Salazar
Ramon M Salazar
MGMary P Gronberg
Mary P Gronberg
CSCarlos Sjogreen
Carlos Sjogreen
MYMing Yang
Ming Yang
Objective. To evaluate the impact of beam mask implementation and data aggregation on artificial intelligence-based dose prediction accuracy in proton therapy, with a focus on scenarios involving limited or highly heterogeneous datasets. Approach. In this study, 541 prostate and 632 head and neck (H&N) proton therapy plans were used to train and evaluate convolutional neural networks designed for the task of dose prediction. Datasets were grouped by anatomical site and beam configuration to assess the impact of beam masks—graphical depictions of radiation paths—as a model input. We also evaluated the effect of combining datasets. Model performance was measured using dose-volume histograms (DVHs) scores, mean absolute error, mean absolute percent error, dice similarity coefficients (DSCs), and gamma passing rates. Main results. DSC analysis revealed that the inclusion of beam masks improved dose prediction accuracy, particularly in low-dose regions and for datasets with diverse beam configurations. Data aggregation alone produced mixed results, with improvements in high-dose regions but potential degradation in low-dose areas. Notably, combining beam masks and data aggregation yielded the best overall performance, effectively leveraging the strengths of both strategies. Additionally, the magnitude of the improvements was larger for datasets with greater heterogeneity, with the combined approach increasing the DSC score by as much as 0.2 for a subgroup of H&N cases characterized by small size and heterogeneity in beam arrangement. DVH scores reflected these benefits, showing statistically significant improvements (p < 0.05) for the more heterogeneous H&N datasets. Significance. Artificial intelligence-based dose prediction models incorporating beam masks and data aggregation significantly improve accuracy in proton therapy planning, especially for complex cases. This technique could accelerate the planning process, enabling more efficient and effective cancer treatment strategies.

5 February 2025 in Cancers
Verified
Journal Article
Open access
PDF file
HWHe C. Wang
He C. Wang
FAFahed M. Alsanea
Fahed M. Alsanea
DRDong Joo Rhee
Dong Joo Rhee
Xiaodong ZhangXiaodong Zhang
Xiaodong Zhang
WLWei Liu
Wei Liu
Jack PhanJack Phan
Jack Phan
Background/Objectives: Stereotactic body radiation therapy (SBRT) for skull base reirradiation is particularly challenging, as patients have already received substantial radiation doses to the region, and nearby normal organs may have approached their tolerance limit from prior treatments. In this study, we reviewed the characteristics and capabilities of four advanced external beam radiation delivery systems and four modern treatment planning systems and evaluated the treatment plan quality of each technique using skull base reirradiation patient cases. Methods: SBRT plans were generated for sixteen skull base reirradiation patients using four modalities: the GK plan for the Elekta Leksell Gamma Knife Perfexion/ICON, the CyberKnife (CK) plan for the Accuray CyberKnife, the intensity-modulated proton therapy (IMPT) plan for the Hitachi ProBeat-FR proton therapy machine, and the volumetric-modulated arc therapy (VMAT) plan for the Varian TrueBeam STx. These plans were evaluated and compared using two novel gradient indices in addition to traditional dosimetry metrics for targets and organs at risk (OARs). The steepest border gradient quantified the percent prescription dose fall-off per millimeter at the boundary between the target and adjacent critical structures. This gradient index highlighted the system’s ability to spare nearby critical OARs. The volume gradient assessed the extent of dose spread outside the target toward the patient’s body. Results: All plans achieved comparable target coverage and conformity, while IMPT and VMAT demonstrated significantly better uniformity. The GK plans exhibited the highest border gradient, up to 20.9%/mm, followed by small-spot-size IMPT plans and CK plans. Additionally, IMPT plans showed the benefit of reduced dose spread in low-dose regions and the lowest maximum and mean doses to the brainstem and carotid artery. Conclusions: The advanced external beam radiotherapy modalities evaluated in this study are well-suited for SBRT in skull base reirradiation, which demands precise targeting of tumors with highly conformal doses and steep dose gradients to protect nearby normal structures.

1 April 2019 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Open access
SGStephen Grant
Stephen Grant
TWTyler Williamson
Tyler Williamson
CFClifton David Fuller
Clifton David Fuller
DRDavid Rosenthal
David Rosenthal
SFSteven J Frank
Steven J Frank
BGBrandon Gunn
Brandon Gunn